Author:
Macheras Panos,Tsekouras Athanasios A.
Publisher
Springer International Publishing
Reference9 articles.
1. Schuirmann DJ (1987) A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 15:657–680. https://doi.org/10.1007/BF01068419
2. EMA (2010) Guideline on the investigation of bioequivalence. London
3. McGilveray IJ, Midha KK, Skelly JP, Dighe S, Doluisio JT, French IW, Karim A, Burford R (1990) Consensus report from “bio international '89”: issues in the evaluation of bioavailability data. J Pharm Sci 79:945–946. https://doi.org/10.1002/jps.2600791022
4. Blume HH, Midha KK (1993) Bio-international 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci 82:1186–1189. https://doi.org/10.1002/jps.2600821125
5. McGilveray IJ (1995) An overview of problems and progress at bio-internationals ‘89 and ‘92. In: Blume H, Midha K (eds) Bio-international 2, bioavailability, bioequivalence and pharmacokinetic studies. Medpharma Scientific publishers, Stuttgart, pp 109–115